Old Web
English
Sign In
Acemap
>
Paper
>
Abstract 717: JAK2/STAT3 induces erlotinib-resistance in lung cancer cells harboring EGFR-activating mutations
Abstract 717: JAK2/STAT3 induces erlotinib-resistance in lung cancer cells harboring EGFR-activating mutations
2011
Daijiro Harada
Nagio Takigawa
Kadoaki Ohashi
Eiki Ichihara
Toshio Kubo
Hiromasa Takeda
Hiromi Kashihara
Katsuyuki Hotta
Mitsune Tanimoto
Katsuyuki Kiura
Keywords:
STAT3
Erlotinib
Lung cancer
Cancer research
Immunology
Medicine
jak2 stat3
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]